Five Towns Neurology PC — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$375	1
2021	Research	$750	1
2020	Research	$11,690	7
2019	Research	$8,228	1

Breakdown

Who paid Research payments · program years 2019–2022

Mallinckrodt Hospital Products Inc. $9,434 4 payments
Mallinckrodt Enterprises LLC $8,228 1 payment
Genzyme Corporation $2,250 4 payments
Novartis Pharmaceuticals Corporation $1,131 1 payment

Studies the money was for Research payments · program years 2019–2022

Mallinckrodt Acthar Registry $17,662 5 payments
A prospective, multicenter, observational, post-authorization safety study (PASS) to evaluate the long term safety profile of LEMTRADA (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (RMS) $2,250 4 payments
Long Term Prospective Multinational Parallel Cohort Study Monitoring Safety in Patients With Multiple Sclerosis Newly Started With Fingolimod Once Daily Or Treated With Another Approved Disease Modifying Therapy $1,131 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.